missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ CXCL9/MIG Antibody (Novimmune patent anti-CXCL9) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Marque: Novus Biologicals™ NBP3-28413-100ug
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
CXCL9/MIG Monoclonal antibody specifically detects CXCL9/MIG in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Spécification
| CXCL9/MIG | |
| Monoclonal | |
| Unconjugated | |
| Q07325 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| Novimmune patent anti-CXCL9 | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| chemokine (C-X-C motif) ligand 9, CMK, crg-10, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Humig, MIGSmall-inducible cytokine B9, monokine induced by gamma interferon, SCYB9Monokine induced by interferon-gamma | |
| CXCL9 | |
| 100 μg | |
| Biologically Active Proteins, Chemokines and Cytokines, Signal Transduction | |
| 4283 | |
| Human | |
| Purified |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu